H. Biliran

发表

Anti-invasive and Antimetastatic Activities of Ribosomal Protein S6 Kinase 4 in Breast Cancer Cells

Sanjeev Banerjee, F. Sarkar, D. Liao, 2008, Clinical Cancer Research.

Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells.

A. Raz, H. Biliran, H. Kim, 1999, Cancer research.

Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis

S. Sheng, J. Abrams, H. Biliran, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Aberrant Expression of X-Linked Genes RbAp46, Rsk4, and Cldn2 in Breast Cancer

D. Grignon, F. Sarkar, Xiukun Lin, 2007, Molecular Cancer Research.

Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.

H. Biliran, S. Sheng, 2001, Cancer research.

Inhibition of Pericellular Urokinase-type Plasminogen Activator System by Endogenous Tumor Suppressive Maspin 1

S. Sheng, H. Biliran, 2001 .

Induction of Apoptosis and Anoikis by Bit1 in Pancreatic Cancer Cells

H. Biliran, P. Karmali, T. Pham, 2013 .

Induction of Apoptosis and Anoikis by Bit 1 in Pancreatic Cancer Cells

H. Biliran, P. Karmali, T. Pham, 2013 .

c-Myc–Induced Chemosensitization Is Mediated by Suppression of Cyclin D1 Expression and Nuclear Factor-κB Activity in Pancreatic Cancer Cells

Sanjeev Banerjee, F. Sarkar, Jiusheng Wu, 2007, Clinical Cancer Research.

Protein Kinase D Is a Positive Regulator of Bit1 Apoptotic Function*

E. Ruoslahti, E. Pasquale, H. Biliran, 2008, Journal of Biological Chemistry.

TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.

M. Raj, H. Biliran, S. Ireland, 2014, Biochemical and biophysical research communications.

Cell Cycle Arrest and Inhibition of Anoikis by Galectin-3 in Human Breast Epithelial Cells 1

A. Raz, H. Biliran, H. Kim, 1999 .

TLE1 inhibits anoikis and promotes tumorigenicity in human lung cancer cells through ZEB1-mediated E-cadherin repression

A. Abdel‐Mageed, H. Biliran, S. Ireland, 2017, Oncotarget.

The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells

A. Abdel‐Mageed, H. Biliran, Renwei Chen, 2016, PloS one.

Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.

E. Ruoslahti, Meng Yang, R. Hoffman, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy.

F. Sarkar, D. Liao, A. Thakur, 2007, Critical reviews in oncogenesis.

The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.

R. Sager, H. Biliran, S. Sheng, 2000, Cancer research.

Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin.

A. Abdel‐Mageed, H. Biliran, S. Ireland, 2018, Biochemical and biophysical research communications.

The Anoikis Effector Bit1 Displays Tumor Suppressive Function in Lung Cancer Cells

H. Biliran, S. Ireland, Renwei Chen, 2014, PloS one.

Bit1 in anoikis resistance and tumor metastasis.

E. Ruoslahti, H. Biliran, S. Ireland, 2013, Cancer letters.

TLE1 Is an Anoikis Regulator and Is Downregulated by Bit1 in Breast Cancer Cells

E. Ruoslahti, H. Biliran, S. Ireland, 2012, Molecular Cancer Research.

TLE 1 is an anoikis regulator and is downregulated by Bit 1 in breast cancer cells

E. Ruoslahti, H. Biliran, S. Ireland, 2012 .

Cell Cycle , Cell Death , and Senescence TLE 1 Is an Anoikis Regulator and Is Downregulated by Bit 1 in Breast Cancer Cells

E. Ruoslahti, H. Biliran, S. Ireland, 2012 .

Metastasis of Tumor Cells Is Enhanced by Downregulation of Bit1

E. Ruoslahti, H. Biliran, P. Karmali, 2011, PloS one.

Overexpression of Cyclin D1 Promotes Tumor Cell Growth and Confers Resistance to Cisplatin-Mediated Apoptosis in an Elastase-myc Transgene–Expressing Pancreatic Tumor Cell Line

H. Heng, Sanjeev Banerjee, F. Sarkar, 2005, Clinical Cancer Research.

The role of X-linked genes in breast cancer

A. Thakur, A. Bollig, H. Biliran, 2005, Breast Cancer Research and Treatment.

Anoikis effector Bit1 negatively regulates Erk activity

E. Ruoslahti, H. Biliran, J. Pascual, 2008, Proceedings of the National Academy of Sciences.

Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.

D. Liao, A. Thakur, Yuan Sun, 2007, Cancer research.

Complementary/Alternative Medicine Strategies for Prevention and or Cure of Breast Cancer: A Review

M. Abdraboh, R. Gaur, M. Raj, 2015 .

Abstract LB-171: Throwing the 'book' at the cancer cell speciifically: A new paradigm and a new strategy for cancer prevention and cure

M. Raj, H. Biliran, S. Ireland, 2017 .

Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.

S. Sheng, Xiaohua Li, J. Anagli, 2006, Cancer research.

c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.

Sanjeev Banerjee, F. Sarkar, H. Biliran, 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.